Beyond the conventional attention on amyloid Aβ and tau changes, investigators are increasingly pinpointing novel pharmacological targets for this disease. These feature affecting brain inflammation through blocking microglial function, interacting with neural connection dysfunction – particularly associated with excitatory neurotransmitter tran… Read More